Commentary: Digital Forensics Are New Normal in the Fight Against Graft

Bribery risk is serious in China. In 2014, GlaxoSmithKline (China) Investment Co. Ltd. (a subsidiary company of GlaxoSmithKline in China) received a criminal fine of 3 billion yuan ($433 million) for giving bribes to doctors. And several senior executives of the company received criminal punishments as well. In face of the rampant risk, the Chinese government has been trying very hard to crack down on bribery including finding better ways to investigate and find evidence, a problem for which digital forensics technology could be a solution.